BVF INC/IL Portfolio

Auto-discovered 13F filer (Top-2000 by latest reported value).

SEC 13F CIK: 0001056807

What is a 13F filing? Who files one and when · What 13F filings can't tell you

MidFocusedHealth TiltHigh Turnover how tags are computed

Q3 2026 · 47 positions · Total reported value $3.04B · Top-10 concentration 66.0% · Updated 2026-11-17

Last updated: 2026-11-17 · Source: SEC EDGAR Form 13F-HR

Turnover: 41.7% · 4 new · 15 cut · 1 exited

Active Share (vs S&P 500): 100.0% · vs QQQ: 100.0% — share of the book that differs from index weights (higher = more active) · ranking

Est. Qtr Return (Q2 2026 → Q3 2026): -15.2% · vs SPY -17.3% · Prev Value $3.91B — last quarter positions weighted by this quarter price moves · ranking

Est. QTD Return (Q3 2026 → newest close): -2.8% · vs SPY -5.0% · Latest Value $3.04B — latest reported positions valued at quarter-to-date price moves (still in progress) · ranking

In its Q3 2026 13F filing, BVF INC/IL disclosed 47 equity positions with a combined reported value of $3.04B. The filing implies a focused portfolio: its ten largest positions account for 66.0% of reported value. HoldingsHub classifies the profile as Mid / Focused / Health Tilt / High Turnover.

The largest disclosed positions as of Q3 2026 were RVMD ($505.05M), KYMR ($432.86M), GHRS ($203.11M). By sector, the heaviest allocations are Health Care 99.4%, Financials 0.2%. Versus the prior quarter, allocation shifted toward Health Care (+7.8pp) and away from Other (-7.9pp).

Versus the prior quarter, BVF INC/IL opened 4 new positions, trimmed 15 and fully exited 1, a turnover rate of 41.7% of positions. The portfolio's overlap with the prior quarter was 90% of names.

The largest new positions opened in Q3 2026 were PYXS ($27.55M), ALEC ($18.59M), TLGYF ($6.25M).

Of the 1 positions fully exited versus the prior quarter, the largest were XOMA ($322.72M).

Figures come from the fund's SEC Form 13F filing. 13F reports are filed within 45 days of quarter end and cover long positions of $100,000 or more; they exclude short positions and non-13F asset classes, so treat this page as a quarter-end snapshot rather than the fund's live book.

New Positions (Q3 2026)

  • PYXS PYXIS ONCOLOGY INC · $27.55M
  • ALEC ALECTOR INC · $18.59M
  • TLGYF TCGX ACQUISITION CORP · $6.25M
  • RACD RESEARCH ALLIANCE CORP IV · $5.92M

Fully Exited (vs previous quarter)

  • XOMA XOMA ROYALTY CORPORATION · prev qtr: $322.72M

Insider Transactions (Form 4)

Latest BVF INC/IL buys and sells reported on SEC Form 4 — filed within two business days when the fund's ownership in a stock crosses 10%.

Transaction date Activity Security Shares Price Filing
2026-07-14 U XOMA Royalty Corp 772,000 — SEC filing
2026-07-14 U XOMA Royalty Corp 412,000 — SEC filing
2026-07-14 U XOMA Royalty Corp 2,773,545 — SEC filing
2026-07-14 U XOMA Royalty Corp 3,635,758 — SEC filing
2026-06-26 Sell Kymera Therapeutics, Inc. 51,858 $106.50 SEC filing
2026-06-26 Sell Kymera Therapeutics, Inc. 113,289 $106.50 SEC filing
2026-06-26 Sell Kymera Therapeutics, Inc. 627,597 $106.50 SEC filing
2026-06-26 Sell Kymera Therapeutics, Inc. 837,914 $106.50 SEC filing

All insider transactions →

Fund Profile

BVF INC files quarterly US equity holdings with the SEC on Form 13F. Its latest filing (Q3 2026) lists 47 positions worth $3.04B in total. HoldingsHub carries 13 quarters of its filings (Q3 2023–Q3 2026).

Portfolio Structure

  • 47 positions · $3.04B reported value (Q3 2026)
  • Top 10 holdings = 66.0% of reported value
  • Largest position: RVMD (REVOLUTION MEDICINES INC) at 16.6%
  • Average position size: $64.68M

Sector Tilt

  • Health Care 99.4%
  • Financials 0.2%
  • Materials 0.0%
  • (classified holdings cover 100% of value)

Quarterly Activity

  • Q3 2026: 4 new, 7 added, 15 reduced, 1 exited
  • 21 positions unchanged

Generated from the firm's public SEC Form 13F and ADV filings. It states what the firm has reported — not an evaluation of its strategy, and not investment advice.

AI Rebalance Analysis

1. Overall direction and market view: The fund is actively rebalancing with a bullish tilt in Health Care, increasing exposure to select biotech/therapeutics (e.g., ALKS, STOK, TYRA) while trimming others (e.g., RVMD, XNCR, NKTR), suggesting targeted bets on pipeline catalysts or undervalued assets. 2. Key moves: - Added: ALKS (+32.1% shares), STOK (+41.7% shares), TYRA (+185.6% shares). - Reduced: RVMD (-17.0% shares), XNCR (-12.7% shares), NKTR (-10.8% shares), ZYME (-5.1% shares). 3. Portfolio structure: Highly active, concentrated in Health Care (100% of top 10), with high risk appetite (small/mid-cap biotech focus, significant share swings). 4. Per-holding one-liner: - RVMD: Revolution Medicines (oncology). - KYMR: Kymera Therapeutics (rare disease). - GHRS: GH Research (neurodegenerative). - MLTX: Moonlake Immunotherapeutics (autoimmune). - XNCR: Xencor (antibody engineering). - NKTR: Nektar Therapeutics (oncology/pain). - ALKS: Alkermes (CNS/psychiatry). - STOK: Stoke Therapeutics (RNA therapeutics). - TYRA: Tyra Biosciences (oncology). - ZYME: ZymeWorks (oncology). 5. Style summary: Aggressive biotech fund with conviction-driven trades, adding high-growth pipeline names and reducing laggards.

Generated by GLM-4.5-flash from the latest 13F holdings and quarter-over-quarter changes. For reference only, not investment advice. · AI generated 2026-11-17 09:54

Sector Allocation

Health Care 99.4%
Financials 0.2%
Materials 0.0%
Other 0.4%
Sort by: Value · CSV
# Shares Value Weight Allocation Change
1 2.46M $505.05M 16.61%
16.61%
Reduce
2 3.87M $432.86M 14.24%
14.24%
Hold
3 8.65M $203.11M 6.68%
6.68%
Hold
4 16.00M $187.22M 6.16%
6.16%
Hold
5 6.23M $155.36M 5.11%
5.11%
Reduce
6 2.13M $129.20M 4.25%
4.25%
Reduce
7 2.85M $115.36M 3.79%
3.79%
Add
8 3.61M $93.83M 3.09%
3.09%
Add
9 4.22M $92.20M 3.03%
3.03%
Add
10 3.46M $91.77M 3.02%
3.02%
Reduce
11 5.75M $88.27M 2.90%
2.90%
Hold
12 2.69M $84.16M 2.77%
2.77%
Reduce
13 607.15K $83.74M 2.75%
2.75%
Reduce
14 6.69M $71.65M 2.36%
2.36%
Reduce
15 19.82M $51.93M 1.71%
1.71%
Hold
16 4.28M $51.02M 1.68%
1.68%
Reduce
17 17.05M $49.62M 1.63%
1.63%
Add
18 5.30M $45.76M 1.50%
1.50%
Hold
19 3.09M $45.14M 1.49%
1.49%
Add
20 2.88M $41.20M 1.35%
1.35%
Hold
21 1.23M $37.28M 1.23%
1.23%
Reduce
22 8.28M $35.02M 1.15%
1.15%
Reduce
23 407.23K $34.81M 1.15%
1.15%
Reduce
24 3.50M $34.58M 1.14%
1.14%
Add
25 11.83M $27.55M 0.91%
0.91%
New
26 2.36M $25.44M 0.84%
0.84%
Hold
27 28.16M $24.51M 0.81%
0.81%
Hold
28 3.00M $23.31M 0.77%
0.77%
Hold
29 5.84M $20.86M 0.69%
0.69%
Hold
30 1.25M $20.17M 0.66%
0.66%
Hold
31 2.35M $19.43M 0.64%
0.64%
Hold
32 10.05M $18.59M 0.61%
0.61%
New
33 6.29M $15.92M 0.52%
0.52%
Hold
34 233.30K $15.27M 0.50%
0.50%
Reduce
35 907.41K $13.91M 0.46%
0.46%
Reduce
36 4.05M $11.02M 0.36%
0.36%
Add
37 765.29K $7.12M 0.23%
0.23%
Hold
38 500.00K $6.25M 0.21%
0.21%
New
39 500.00K $5.92M 0.20%
0.20%
New
40 500.00K $5.36M 0.18%
0.18%
Hold
41 1.35M $5.19M 0.17%
0.17%
Hold
42 1.11M $5.08M 0.17%
0.17%
Hold
43 1.58M $4.57M 0.15%
0.15%
Reduce
44 686.04K $2.53M 0.08%
0.08%
Hold
45 5.56M $1.75M 0.06%
0.06%
Hold
46 945.40K $189.18K 0.01%
0.01%
Hold
47 25.00K $47.25K 0.00%
0.00%
Reduce

FAQ

What did BVF INC/IL buy in 2026-Q3?

In its 2026-Q3 13F filing, BVF INC/IL reported 47 equity positions worth $3.04B in aggregate; its largest disclosed positions were RVMD ($505.05M), KYMR ($432.86M), GHRS ($203.11M).

How large is BVF INC/IL's portfolio?

BVF INC/IL reported $3.04B of long equity holdings across 47 positions as of 2026-Q3. Top-10 holdings account for 66.0% of reported value.

What is BVF INC/IL's investment style?

HoldingsHub classifies the portfolio as Mid / Focused / Health Tilt / High Turnover, computed from size, concentration, sector tilt and turnover.

Where does this data come from?

All figures are computed from the fund's SEC Form 13F quarterly filing, which must be filed within 45 days of quarter end for long positions of $100,000 or more.

Embed this fund on your site

Copy the snippet below to show this fund's live top holdings on your blog or forum — free, auto-updating, links back to HoldingsHub.

<iframe src="https://holdingshub.top/funds/bvf-inc-il/widget" width="100%" height="520" frameborder="0" loading="lazy" title="HoldingsHub fund holdings"></iframe>

Preview the embeddable widget →